Breaking News

You are here » Indian-Commodity  :  Top News  :  Alembic Pharma gets USFDA's nod for Darifenacin Extended Tablets

12-Dec2017

Alembic Pharma gets USFDA's nod for Darifenacin Extended Tablets

Alembic Pharmaceuticals has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Darifenacin Extended-Release Tablets, 7.5 mg and 15 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Enablex Extended-Release Tablets, 7.5 mg and 15 mg, of Allergan Pharmaceuticals. Darifenacin Extended-Release Tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency.

Darifenacin Extended-Release Tablets, 7.5 mg and 15 mg, have an estimated market size of $64 million for twelve months ending December 2016 according to IMS. The company now has a total of 70 ANDA approvals (62 final approvals and 8 tentative approvals) from USFDA.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907. The company manufactures and markets generic pharmaceuticals products all over the world.


Related News

View all news

Jeera futures trade higher on uptick in demand

Jeera futures traded higher on NCDEX, due to enlargement in demand by market players tracking uptick in demand from spot domestic and export markets. However, improvement in cumin acreage has capped some......

Crude oil futures end higher as OPEC decides to cut production

Crude oil futures ended sharply higher on Friday after OPEC and non-OPEC members reached an agreement to cut crude production next year. Oil prices had stayed weak early on in the session amid doubts over......

Gold futures trade tad higher on Thursday

Gold futures trade marginally higher on Thursday, owing to a sharp correction in equity markets and a softer dollar as the investors  awaited for cues on the Federal Reserve's pace of interest-rate......

Top News

View all news

Arrow Greentech's arm gets approval to manufacture mouth dissolving strips

Arrow Greentech's wholly owned subsidiary (WOS) company -- Avery Pharmaceuticals, also known as Arrow Rx has received an approval for site plan to manufacture mouth dissolving strips from Food &......

Essel Propack issuing commercial papers worth Rs 50 crore

Essel Propack is issuing Commercial Papers (CPs) for Rs 50 crore on private placement basis and will have date of maturity as March 13, 2019. The CPs for Rs 50 crore with date of maturity as December 13,......

Escorts, Kubota join hands for global leadership

Escorts and Kubota Corporation have joined hands for their global joint venture (JV) to manufacture high end technology tractors for domestic and export geographies. The JV will leverage leading Japanese......